Yann Echelard - Net Worth and Insider Trading

Yann Echelard Net Worth

The estimated net worth of Yann Echelard is at least $5 Million dollars as of 2024-09-20. Yann Echelard is the Director of TG Therapeutics Inc and owns about 201,848 shares of TG Therapeutics Inc (TGTX) stock worth over $5 Million. Details can be seen in Yann Echelard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yann Echelard has not made any transactions after 2023-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Yann Echelard

To

Yann Echelard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yann Echelard owns 1 companies in total, including TG Therapeutics Inc (TGTX) .

Click here to see the complete history of Yann Echelard’s form 4 insider trades.

Insider Ownership Summary of Yann Echelard

Ticker Comapny Transaction Date Type of Owner
TGTX TG Therapeutics Inc 2023-01-06 director

Yann Echelard Latest Holdings Summary

Yann Echelard currently owns a total of 1 stock. Yann Echelard owns 201,848 shares of TG Therapeutics Inc (TGTX) as of January 6, 2023, with a value of $5 Million.

Latest Holdings of Yann Echelard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TGTX TG Therapeutics Inc 2023-01-06 201,848 24.04 4,852,426

Holding Weightings of Yann Echelard


Yann Echelard Form 4 Trading Tracker

According to the SEC Form 4 filings, Yann Echelard has made a total of 2 transactions in TG Therapeutics Inc (TGTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in TG Therapeutics Inc is the acquisition of 9,000 shares on January 6, 2023, which cost Yann Echelard around $95,760.

Insider Trading History of Yann Echelard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yann Echelard Trading Performance

GuruFocus tracks the stock performance after each of Yann Echelard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yann Echelard is 43.33%. GuruFocus also compares Yann Echelard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yann Echelard within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yann Echelard's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yann Echelard

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 71.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 65.56 LIMIT LIMIT LIMIT LIMIT LIMIT

Yann Echelard Ownership Network

Ownership Network List of Yann Echelard

No Data

Ownership Network Relation of Yann Echelard

Insider Network Chart

Yann Echelard Owned Company Details

What does TG Therapeutics Inc do?

Who are the key executives at TG Therapeutics Inc?

Yann Echelard is the director of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .

TG Therapeutics Inc (TGTX) Insider Trades Summary

Over the past 18 months, Yann Echelard made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 65,787 shares made by Sagar Lonial , a net sale of 121,514 shares made by Sean A Power , and a net sale of 39,500 shares made by Laurence N Charney .

In summary, during the past 3 months, insiders sold 0 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 226,801 shares of TG Therapeutics Inc (TGTX) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 126,801 shares.

TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TG Therapeutics Inc Insider Transactions

No Available Data

Yann Echelard Mailing Address

Above is the net worth, insider trading, and ownership report for Yann Echelard. You might contact Yann Echelard via mailing address: C/o Lfb Biotechnologies, S.a.s., 3, Avenue Des Tropiques Les Ulis, Courtaboeuf I0 91958.

Discussions on Yann Echelard

No discussions yet.